| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/14/2005 | WO2004037975A3 Composition and method for imaging cells |
| 04/14/2005 | WO2004035676A3 Antisense modulation of notch (drosophila) homolog 4 expression |
| 04/14/2005 | WO2004033656A3 Gene profiling of single or multiple cells |
| 04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
| 04/14/2005 | WO2004024069A3 Novel compositions and methods for the treatment of immune-related diseases |
| 04/14/2005 | WO2004022764A9 Use of malate dehydrogenase for nadh regeneration |
| 04/14/2005 | WO2004020580A3 Single nucleotide polymorphisms diagnostic for schizophrenia |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | WO2004007687A3 Methods to construct multimeric dna and polymeric protein sequences as direct fusions or with linkers |
| 04/14/2005 | WO2003086453A9 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 04/14/2005 | WO2003083069A3 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 04/14/2005 | WO2003073983A3 Methods and compositions in treating pain using diacylglycerol kinase epsilon |
| 04/14/2005 | WO2003040322A3 Promoters for regulation of gene expression in plant roots |
| 04/14/2005 | WO2003029278A3 Il10-r: modulators of lymphocyte activation |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003002753A3 Diagnostic assays for parvovirus b19 |
| 04/14/2005 | WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2005 | WO2002010396A9 Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
| 04/14/2005 | US20050081268 Transgenic plant comprising luciferase sequences for use as tool in luminescent enhancement plant bioactivity |
| 04/14/2005 | US20050081267 Novel genes for conditional cell ablation |
| 04/14/2005 | US20050081266 Modulation of storage organs |
| 04/14/2005 | US20050081265 Maize chloroplast protein synthesis elongation factors and methods of use for same |
| 04/14/2005 | US20050081264 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 04/14/2005 | US20050081263 Cholorophyllases |
| 04/14/2005 | US20050081262 The DMI1 gene encodes a protein that is required for the early steps of bacterial and fungal symbioses |
| 04/14/2005 | US20050081261 Using vector comprising nucleotide sequences coding methyltransferase to generate plants with larger seed size; tissue engineering |
| 04/14/2005 | US20050081260 nucleotide sequence or complements that code polypeptides having synthetase enzyme activity, used to alter enzyme levels in transformed host cells |
| 04/14/2005 | US20050081259 Using vector comprising nucleotide sequences coding protoporphyrinogen oxidase to transform chloroplast and generate herbicide resistant plants |
| 04/14/2005 | US20050081258 Using DNA fragment between 400 and 800 nucleotides to causee insertional modification to plant genomes; site directed mutagenesis |
| 04/14/2005 | US20050081257 Method of producing non-human mammals |
| 04/14/2005 | US20050081256 Transgenic mammal comprising regulatory sequences which permit for preferential selection of sex chromosome in mammalian offspring; sex determination; tissue engineering |
| 04/14/2005 | US20050080773 Network drawing system and network drawing method |
| 04/14/2005 | US20050080251 Method of separation using aromatic thioether ligands |
| 04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
| 04/14/2005 | US20050080241 Human hepatoma-derived growth factor 5, its encoding sequence, method for producing it and the uses of it |
| 04/14/2005 | US20050080234 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080033 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/14/2005 | US20050080032 Modulating expression of an endogenous marine invertebrate gene or an endogenous gene in a pathogen that infects marine invertebrate by administering to invertebrate at least one dsRNA that comprises a sequence having substantial sequence homology to the endogenous pathogen gene |
| 04/14/2005 | US20050080031 Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV |
| 04/14/2005 | US20050080030 Amplifying efficiency of transfection, providing aggregation, exposing to vector, monitoring efficiency of transfection |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080027 Methods enabling the production yield of viral vectors derived from piroviruses to be improved by using DNA methylation inhibitors and/or Herpes viruses in the production of viral vectors derived from parvoviruses; suitable for transferring genes into mammalian cells, in particular into human cells |
| 04/14/2005 | US20050080026 Nucleic acid molecule of MAP kinase interacting kinase gene family or polypeptide encoded thereby or fragment or variant of nucleic acid molecule, polypeptide or antibody, aptamer or receptor recognizing a nucleic acid molecule of gene family or polypeptide encoded thereby; treating metabolic diseases |
| 04/14/2005 | US20050080014 Thrombopoietic compounds |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079619 Using wreck and check molecular genetics as tool to identify gene sequences associated with virulence, pathogenicity and essential functioning of diploid pathogenic fungi; finding targets for antifungal agent discovery |
| 04/14/2005 | US20050079618 Host cells deficient for mismatch repair and their use in methods for inducing homologous recombination using single-stranded nucleic acids |
| 04/14/2005 | US20050079617 Increasing carbon flow into a metabolic pathway of a phosphotransferase transport system, glucose transport double mutant via transformation and expression with vector comprising galactose permease and glucokinase activity; bioreactor and heterologous gene expression |
| 04/14/2005 | US20050079616 Method of transducing ES cells |
| 04/14/2005 | US20050079615 Using plasmid to transfer and expression exogenous nucleotide sequences in cells or vascularized multi-cellular organism; heterologus gene expression; bioreactors; gene therapeutics; genetic vaccination |
| 04/14/2005 | US20050079614 Controlling endogenous gene expression via heterochromatic small interfering RNA; gene expression inhibition |
| 04/14/2005 | US20050079610 Using short interfering RNA's specific to oncogene (fos) as tool in prevention and treatment of infection, allergies, cell proliferatiove, inflammatory and autoimmune diseases |
| 04/14/2005 | US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2005 | US20050079601 Apparatus comprising rotatable mirrors and ultraviolet emission source for use as tool in DNA and genomic analysis |
| 04/14/2005 | US20050079595 Expression vector comprising nucleotide sequences coding hydrolase for use in generating enantimorphic carboxylic acid; agrochemicals and pharmeceuticals; drug design |
| 04/14/2005 | US20050079593 Modified enzymes having polymer conjugates |
| 04/14/2005 | US20050079592 Device and method for manufacturing bead array, and method for detecting target substance |
| 04/14/2005 | US20050079586 Enzymatic polypeptide for use as tool in production of D-ribulose-5-phosphate in bacteria; bioreactors |
| 04/14/2005 | US20050079585 Complement depletion using recombinant human C3-derivatives |
| 04/14/2005 | US20050079584 Modified factor VIII |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079582 chimeric polypeptide molecules inhibits neoplastic cell growth or inhibits endothelial cell growth |
| 04/14/2005 | US20050079581 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 04/14/2005 | US20050079580 Novel human proteins and polynucleotides encoding the same |
| 04/14/2005 | US20050079576 Binding polypeptide, for use in the detection and treatment of prostate cancer |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079574 Polypeptide fusion comprising monoclonal antibody complementary determining regions for use as immunotherapeutics and diagnostics |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079571 Phosphate limited inducible promoter and a bacillus expression system |
| 04/14/2005 | US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors |
| 04/14/2005 | US20050079547 Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy |
| 04/14/2005 | US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 04/14/2005 | US20050079539 Novel gene encoding brain specific membrane protein |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079535 Isolating nucleic acid from solution via adsorption and desorption from substrates; bioanalytics; bioassay |
| 04/14/2005 | US20050079534 Isolating vector from prokaryotic cells using short duration lysis, neutralization and filtration |
| 04/14/2005 | US20050079530 Novel human kinase proteins and polynucleotides encoding the same |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079519 Using matrix composed of immobilized probed comprising 5'-acrylamide moiety to separate and identify preferential single stranded DNA molecules in electric field |
| 04/14/2005 | US20050079512 Using chromatin remodeling as diagnostic tool in detection of transcriptional regulators; gene expression analysis |
| 04/14/2005 | US20050079510 Bead emulsion nucleic acid amplification |
| 04/14/2005 | US20050079504 Assembling messenger RNA database using reduced number of expressed sequence tags; rational drug design; drug screening |
| 04/14/2005 | US20050079501 Using solid support comprising immobilized G-protein coding sequences as tool in detection and diagnosis of cell proliferative disorders |
| 04/14/2005 | US20050079498 Expression vector comprising nucleotide sequences coding polypeptide associated with clavam compounds for use in transformation and generation of cells with improved clavulanic acid production |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079494 Glycinin polypeptide for use as nutrient supplement in foods |
| 04/14/2005 | US20050079492 Using transcription factor direct target gene microarrays of both DNA and corresponding protein/peptide targets for assessing genetic and biochemical interaction profiles in sample populations; chromosomal immunoprecipation and cloning |
| 04/14/2005 | US20050079488 For use in expression constructs for expressing gene products, and methods of using it |
| 04/14/2005 | US20050079212 Methods for encapsulating plasmids in lipid bilayers |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079170 Expression vectors coding antigen binding structure; mixture of protein monomers |
| 04/14/2005 | US20050079168 Virulence genes proteins and their use |
| 04/14/2005 | US20050079163 Administering retroviral vector containing nucleic acid encoding a gene; antiproliferative agents; antitumor agents |
| 04/14/2005 | US20050079160 polynucleotides, small interfering RNA or genetic vectors that inhibit expression of genes that code for osmosis stress resistance proteins, used as nematocides |
| 04/14/2005 | US20050079158 Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof |
| 04/14/2005 | US20050078179 Modulate aptamer and method for detecting target protein by using the same |
| 04/14/2005 | US20050077481 Method of constructing chimeric plant by heavy-ion beam irradiation |
| 04/14/2005 | DE10344545A1 New isolated, truncated capsid protein C1 of beak and feather disease virus, useful in vaccines and as a diagnostic agent, and its encoding nucleic acid |